Inhibitors of gangliosides metabolism for the treatment of motor neuron diseases
US11065238B2 · kind B2 · utility
0Cited by
38References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 3, 2017 |
| Grant date | Jul 20, 2021 |
| Priority date | — |
| Expiry date | Nov 3, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to inhibitors of gangliosides metabolism for treating motor neuron diseases, in particular hereditary spastic paraplegias.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.